failure to respond or late response
on 06 Jan 2023
Last Applicant/ Owned by
201 Haskins Way
South San Francisco
CA
94080
Serial Number
90580467 filed on 15th Mar 2021
Registration Number
N/A
Correspondent Address
Christina L. Martini
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"MANUFACTURING CENTER"
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientifiRead More
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research
Custom manufacture of pharmaceuticals
No 90580467
No Service Mark
No 111076-0047
No
No
No
No
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.15 -
Three circles
The mark consists of the word "LyFE" positioned above the words "Manufacturing Center" surrounded by three incomplete circles each of which has an opening at the right.
Status Date | Action Taken |
---|---|
06th Jan 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
06th Jan 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
31st May 2022 | FINAL REFUSAL WRITTEN |
31st May 2022 | FINAL REFUSAL E-MAILED |
31st May 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
12th Apr 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
11th Apr 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
11th Apr 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
14th Oct 2021 | NON-FINAL ACTION WRITTEN |
14th Oct 2021 | NON-FINAL ACTION E-MAILED |